HPV Vaccination for Boys: Essential to Prevent Cervical Cancer
ADN
Immunizing boys against human papillomavirus is gaining recognition as a crucial strategy in the global effort to eliminate cervical cancer, with experts emphasizing that protecting all genders can significantly reduce transmission and improve public health outcomes.
TL;DR
- Boys’ HPV vaccination rates remain very low worldwide.
- Gender bias in vaccine policy threatens herd immunity goals.
- Universal coverage could dramatically reduce cervical cancer globally.
Rethinking HPV Vaccination Strategies: Boys Left Behind
Despite remarkable progress in the fight against the human papillomavirus (HPV), public health experts warn that neglecting young boys in immunization programs could seriously undermine global efforts to eliminate cervical cancer. The case of South Korea, where only girls are routinely vaccinated, highlights a persistent gender gap that may stand in the way of true herd immunity.
The Lingering Gender Divide
When the first HPV vaccine, known commercially as Gardasil, was introduced back in 2006, it was widely hailed as a breakthrough—mainly for women. Public health messaging and pharmaceutical campaigns focused almost exclusively on preventing cervical cancer, inadvertently perpetuating a kind of gender bias. Overlooked was the fact that HPV can cause other serious cancers in men, including those of the anus, penis, and throat. In countries like South Korea, this has had striking consequences: over two decades, HPV-linked cancers among men have tripled.
The Case for Broadening Vaccination Policies
Recent research led by Professor Abba Gumel at the University of Maryland sheds light on the real impact of excluding boys from vaccination drives. Mathematical modeling reveals that with nearly 88% of Korean girls immunized today, achieving collective protection would require an astonishing 99% coverage among girls alone—a nearly impossible goal. Conversely, extending coverage to just 65% of boys would make herd immunity both attainable and sustainable. Even if vaccination rates among girls were to drop modestly to 80%, similar increases among boys would maintain sufficient community protection.
Several factors explain why expanding vaccine access is now considered crucial:
- The routine vaccination of boys starting in adolescence.
- The inclusion of unvaccinated adult women into national programs.
- A comprehensive public information campaign on all HPV-related risks.
A Global Opportunity for Elimination
Looking ahead, researchers believe that truly universal vaccination could enable the world to eliminate up to 149 out of 181 cervical cancer types by century’s end—provided both genders are systematically included in prevention efforts. As Professor Gumel emphasizes, losing hundreds of thousands of lives each year to a preventable disease should no longer be acceptable. In this light, expanding vaccine access emerges not just as good practice but as a clear imperative for public health worldwide.